Drawing for VEROS BIOLOGICS EXCELLENCE IN BIOLOGIC THERAPIES

USPTO serial 87906227

VEROS BIOLOGICS EXCELLENCE IN BIOLOGIC THERAPIES

Reviewed by CopyMark Law Group

Reg. 5909194Status 710
Filing date
Status date
Registration date
Nov 12, 2019
Examiner
CHANG, KATHERINE S
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with VEROS BIOLOGICS EXCELLENCE IN BIOLOGIC THERAPIES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Daniel P. Mullarkey

DANIEL P. MULLARKEY POLSINELLI PC1401 I Street, NW, Suite 800Polsinelli PCWASHINGTON, DC 20005

Goods and services

ClassDescriptionStatusFirst use
035Medical services, namely, medical billing and medical referrals; Business management of infusion services for physicians; Business management of physician practices; Retail pharmacy servicesSECTION 8 - CANCELLEDFeb 28, 2018
041Providing instruction and training to patients in the field of administering prescribed self-injectable medicationSECTION 8 - CANCELLEDFeb 28, 2018
042Medical services, namely, medical research; Medical laboratory services; Clinical research services in the field of infusion biologic therapiesSECTION 8 - CANCELLEDFeb 28, 2018
044Medical services; Diagnostic services, namely, medical diagnostic testing, monitoring and reporting services; Treatment services, namely, medical treatment services for patients requiring specialty biologics therapy; Healthcare services in the nature of drug and vitamin infusion therapy services; Nursing services; Healthcare services in the nature of in-home medical infusion therapy services; Healthcare services in the nature of providing and administering infusion biologics therapies for transplant, immunology, neurology and hematology; Healthcare services in the nature of immunization services; Healthcare services in the nature of bio-immunization programs; Health care services in the nature of disease management services, namely, providing therapy specific management programs to patients using self-injectable medications; Dispensing of pharmaceuticals; Health care consulting in the field of prescription drug management; Home health care services, namely, dispensing of prescription pharmaceuticals; Preparation and dispensing of medications; clinical outcome services, namely, health assessment services; providing continuum-of-care healthcare services and medical facilities; medical evaluation services, namely, disease management programs; health assessment services in the field of treatment protocols and patient outcomesSECTION 8 - CANCELLEDFeb 28, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 22, 2026C8..CANCELLED SEC. 8 (6-YR)—
Jan 28, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 5, 2025ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 12, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 21, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 17, 2021ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 12, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 5, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 4, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 30, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 30, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 9, 2019IUAFUSE AMENDMENT FILED—
Sep 9, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 16, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 19, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 19, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 30, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 2, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 20, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Dec 20, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 20, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 20, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 17, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 16, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 16, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 28, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 28, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 28, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 24, 2018DOCKASSIGNED TO EXAMINER—
May 15, 2018MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
May 14, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 7, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance